1. Benznidazole and nifurtimox should not be taken by pregnant women or by people with kidney or liver failure.

2. Nifurtimox is also contraindicated for people with a background of neurological or psychiatric disorders.

3. Nifurtimox is registered for the treatment of American trypanosomiasis but not for human African trypanosomiasis.

4. A combination treatment of nifurtimox and eflornithine has been recently introduced (2009).

5. All nifurtimox drugs produced by Bayer HealthCare will be given to WHO for distribution to countries[/nifurtimox.html], ensuring accessibility of the drug to those who need it most.

6. The drugs nifurtimox an eflornithine will be given out in Uganda and the Democratic Republic of Congo.

7. The drugs nifurtimox and eflornithine will be given out in Uganda and the Democratic Republic of Congo.

8. The expanded programme is supported by Bayer HealthCare, which manufactures nifurtimox, a drug used to treat the disease.

9. There are currently two drugs effective in the treatment of Chagas disease, benznidazole and nifurtimox.

10. To kill the parasite Chagas disease can be treated with either benznidazole or nifurtimox.